Hostname: page-component-76d6cb85b7-7262s Total loading time: 0 Render date: 2026-07-14T01:48:55.289Z Has data issue: false hasContentIssue false
  • English
  • Français

MTHFR 677 TT genotype and folate requirements for preventing neural tube defects: is there a case for personalised nutrition?

Published online by Cambridge University Press:  19 October 2012

R. Reilly ,
M. Ward ,
B. McNulty ,
K. Pentieva ,
J. M. Scott ,
B. Marshall ,
A. M. Molloy ,
J. J. Strain  and
H. McNulty
R. Reilly
Affiliation:
Northern Ireland Centre for Food and Health (NICHE), University of Ulster, Coleraine, BT52 1SA
M. Ward
Affiliation:
Northern Ireland Centre for Food and Health (NICHE), University of Ulster, Coleraine, BT52 1SA
B. McNulty
Affiliation:
Northern Ireland Centre for Food and Health (NICHE), University of Ulster, Coleraine, BT52 1SA
K. Pentieva
Affiliation:
Northern Ireland Centre for Food and Health (NICHE), University of Ulster, Coleraine, BT52 1SA
J. M. Scott
Affiliation:
School of Biochemistry and Immunology, Trinity College, Dublin 2, Ireland
B. Marshall
Affiliation:
Causeway Hospital, The Northern Health and Social Care Trust, Coleraine, BT52 1HS
A. M. Molloy
Affiliation:
School of Clinical Medicine, Trinity College, Dublin 2, Ireland
J. J. Strain
Affiliation:
Northern Ireland Centre for Food and Health (NICHE), University of Ulster, Coleraine, BT52 1SA
H. McNulty
Affiliation:
Northern Ireland Centre for Food and Health (NICHE), University of Ulster, Coleraine, BT52 1SA
Rights & Permissions [Opens in a new window]

Abstract

An abstract is not available for this content. As you have access to this content, full HTML content is provided on this page. A PDF of this content is also available in through the ‘Save PDF’ action button.

Given the known protective effect of folic acid (FA) in preventing neural tube defects (NTD), women of reproductive age in most countries worldwide are recommended to take 400 μg/d FA from before conception up to the 12th gestational week; however compliance with this recommendation is typically poor( Reference McNulty, Pentieva and Marshall 1 ). There is a well-established inverse relationship between maternal red cell folate (RCF) concentrations and NTD risk, with a maternal RCF concentration of ≥907 nmol/l associated with the lowest risk of an NTD affected pregnancy( Reference Daly, Kirke and Molloy 2 ). The 677C→T polymorphism in the gene encoding methylenetetrahydrofolate reductase (MTHFR) produces a variant enzyme which results in impaired folate metabolism; women with this genotype are reported to be at increased risk of adverse pregnancy outcomes including NTD. The aim of this investigation was to examine folate status by MTHFR 677C→T genotype in relation to FA usage reported by pregnant women. In particular we considered the timing of commencing FA supplementation.

Data from a previous investigation of women's compliance with current FA recommendations (n 226)( Reference McNulty, Pentieva and Marshall 1 ) were analysed for the purpose of this study.

Figure 1:

Mean (±SEM) Hcy (Left) and RCF (Right) at 14 weeks gestation by MTHFR 677C→T genotype. Probability values refer to interaction obtained from a Two-way Between-group ANOVA (P<0.05); different lowercase letters indicate significant differences between genotype groups by Tukey's post hoc test.

By the 14th gestational week, women with the TT genotype had significantly higher Hcy (P=0.002) and lower RCF (P=0.006) if they had not commenced FA before conception, compared to those that had, whereas these differences were not evident in the other genotype groups. Higher Hcy is linked to a number of adverse pregnancy outcomes( Reference Vollset, Refsum and Irgens 3 ) and RCF at this time reflects maternal folate status over the previous 12 weeks including the critical period of when the neural tube is closing. The majority of women (83%) with the TT genotype who started FA post conception failed to achieve a RCF concentration associated with the lowest risk of having an NTD affected pregnancy( Reference Daly, Kirke and Molloy 2 ). In conclusion, this study indicates the much greater need for women with the MTHFR 677TT genotype to adhere to the specific recommendation of commencing FA prior to conception for the prevention of NTD. These findings have important public health implications given that the frequency of the TT genotype is 10% worldwide but much higher in some populations.

References

1. McNulty, B, Pentieva, K, Marshall, B et al. (2011) Hum Reprod 26, 1530–1536.CrossRefGoogle Scholar
2. Daly, LE, Kirke, PN, Molloy, A et al. (1995) JAMA 274, 1698–1702.CrossRefGoogle Scholar
3. Vollset, SE, Refsum, H, Irgens, LM et al. (2000) Am J Clin Nutr 71, 962–8.CrossRefGoogle Scholar
Figure 0

Figure 1: Mean (±SEM) Hcy (Left) and RCF (Right) at 14 weeks gestation by MTHFR 677C→T genotype. Probability values refer to interaction obtained from a Two-way Between-group ANOVA (P<0.05); different lowercase letters indicate significant differences between genotype groups by Tukey's post hoc test.